Key facts
- It has raised $3.1M; the latest was Early Stage VC in Jul 2025.
- Notable investors include Tech Incubator Program for Startup, Korea Credit Guarantee Fund, D.Camp, STIC Ventures, Woori Venture Partners — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Space LiinTech
- ·The full record, as it builds
Funding rounds
No funding rounds for Space LiinTech are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Space LiinTech
Operator of space-based biopharma company intended for pharmaceutical production platforms for operation in space and microgravity environments. The company's platform provides new drug research, development and production in the microgravity environment of satellites and space stations and its main medicine business models include drug manufacturing through protein crystal growth, stem cell culture and organoid production, enabling biomedical research and pharmaceutical manufacturing firms to enhance drug efficacy and stability through crystallization in space.
- Sector
- Healthcare
- HQ
- Daejeon, South Korea
- Founded
- 2021
- Employees
- 25
- Website
- spaceliintech.com/
- Ownership
- Privately Held (backing)
Space LiinTech doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Space LiinTech shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Space LiinTech in its N-PORT filings yet. We sweep new filings monthly.